Press release
Global Cell and Gene Therapy Market to Reach USD 33.3 Billion by 2034 Driven by Innovation and Expanding Approvals
Cell and Gene Therapy Market
Transforming Patient Care
Cell and gene therapies are reshaping treatment for cancer, rare genetic disorders, and chronic conditions by targeting the root cause of disease rather than just managing symptoms. Breakthrough therapies such as Zolgensma, Luxturna, and CAR-T treatments like Kymriah and Yescarta have proven clinical success, boosting investor confidence and accelerating research. Currently, more than 2,000 CGT candidates are under development globally, with oncology and rare disorders representing over 60% of clinical trials.
To avail Sample Copy of the report @https://www.emergenresearch.com/request-sample/27
Key Market Drivers
Rising Approvals: Regulatory bodies including the U.S. FDA and European Medicines Agency have approved several high-impact therapies in recent years. These include treatments for spinal muscular atrophy, hemophilia, and certain blood cancers. Expedited pathways such as the FDA's RMAT designation and Europe's PRIME program are further supporting faster approvals.
Expanding Rare Disease Pipeline: Over 600 CGT candidates are now in advanced stages of development, many focused on monogenic diseases such as Duchenne muscular dystrophy and sickle cell anemia. Large pharmaceutical companies are strengthening their pipelines through partnerships and acquisitions.
Outcome-Based Reimbursement Models: Governments and payers are testing new pricing models, including outcome-based and installment payment systems, to make these high-cost therapies more accessible.
Trends Shaping the Market
Allogeneic "Off-the-Shelf" Therapies: These donor-derived treatments aim to lower costs and reduce waiting times compared to patient-specific (autologous) therapies.
Next-Gen Gene Editing: Tools like base editing and prime editing are showing potential for safer and more precise treatment.
Point-of-Care Manufacturing: Hospitals are piloting on-site production models to reduce logistics costs and treatment delays.
AI-Driven Innovation: Artificial intelligence is being applied to improve viral vector design, cell selection, and bioprocessing efficiency.
Non-Viral Delivery Methods: Lipid nanoparticles and electroporation are being studied as alternatives to viral delivery, especially for central nervous system diseases.
Combination Therapies in Cancer: Developers are exploring combinations of cell therapies with checkpoint inhibitors to boost effectiveness.
Regenerative Medicine Beyond Cancer: New cell therapies are emerging for conditions like Parkinson's disease, diabetes, and heart failure.
Request Customization In The Report @https://www.emergenresearch.com/request-for-customization/27
Market Restraints
Despite strong progress, challenges remain. The cost of developing a single therapy can exceed USD 1 billion, and treatments often range from USD 500,000 to USD 3 million per patient. Manufacturing complexity and limited global capacity also restrict scalability. Reimbursement hurdles and varying regulatory requirements add further barriers to wider adoption.
Segment Insights
By Therapy Type:
Cell Therapy dominated in 2024, largely driven by CAR-T therapies in blood cancers, with expansion into neurodegenerative and cardiovascular conditions.
Gene Therapy is rapidly growing, supported by approvals such as Zolgensma and Roctavian, and advancements in vector technology.
By Indication:
Oncology holds the largest share, accounting for over 60% of revenues.
Rare Genetic Disorders are the fastest-growing segment, with strong regulatory and reimbursement support.
Neurological Disorders are gaining traction, with clinical trials targeting Parkinson's and spinal cord injuries.
By Vector Type:
Viral Vectors (AAV, lentivirus) dominate the market, widely used for both ex vivo and in vivo therapies.
Non-Viral Vectors are emerging as cost-effective, scalable alternatives with lower immunogenic risks.
By End Use:
Hospitals and Specialty Clinics are the primary users, especially for personalized CAR-T therapies.
Academic and Research Institutes drive early innovation and clinical trials.
Contract Development and Manufacturing Organizations (CDMOs) play a crucial role in providing large-scale production and regulatory compliance.
Browse The Full Cell and Gene Therapy Market Report Description, Along With The Tocs And List Of Facts And Figures @ https://www.emergenresearch.com/industry-report/cell-and-gene-therapy-market
Regional Momentum
Governments in the U.S., Europe, Japan, and China are adopting fast-track regulatory frameworks and reimbursement schemes, encouraging rapid development and commercialization. Expanding manufacturing infrastructure and partnerships between academia and industry are further supporting market growth worldwide.
A few leading players in the cell and gene therapy market include:
Spark Therapeutics LLC
Novartis AG
Gilead Sciences Inc.
Bluebird Bio
GlaxoSmithKline
Celgene Corporation
Shire PLC
Sangamo Biosciences
Voyager Therapeutics
Dimension Therapeutics
Cell and Gene Therapy Market Market Segmentation Analysis
By Therapy Type Outlook (Revenue, USD Billion, 2021-2034)
Cell Therapy
Gene Therapy
By Indication Outlook (Revenue, USD Billion, 2021-2034)
Oncology
Rare Genetic Disorders
Neurological Disorders
Others
By Vector Type Outlook (Revenue, USD Billion, 2021-2034)
Viral Vectors
Non-Viral Vectors
By End-Use Outlook (Revenue, USD Billion, 2021-2034)
Hospitals & Specialty Clinics
Academic & Research Institutes
Contract Development & Manufacturing Organizations (CDMOs)
By Regional Outlook (Revenue, USD Billion, 2021-2034)
North America
U.S.
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Nordics
Asia Pacific
China
India
Japan
South Korea
Australia
Latin America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
UAE
South Africa
Nigeria
Click Here To Buy Now @https://www.emergenresearch.com/select-license/27
Latest Published Reports by Emergen Research:
Atopic Dermatitis Drugs Market
https://www.emergenresearch.com/industry-report/atopic-dermatitis-drugs-market
Insulin Market
https://www.emergenresearch.com/industry-report/insulin-market
Data Center Cooling Market
https://www.emergenresearch.com/industry-report/data-center-cooling-market
Aniline Market
https://www.emergenresearch.com/industry-report/aniline-market
Telescopic Slides Market
https://www.emergenresearch.com/industry-report/telescopic-slides-market
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cell and Gene Therapy Market to Reach USD 33.3 Billion by 2034 Driven by Innovation and Expanding Approvals here
News-ID: 4148142 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Therapy
Visual Arts Therapy Market Future Business Opportunities 2024-2031 | American Ar …
A recent report titled "Visual Arts Therapy Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report additionally features a comprehensive table of contents, figures, tables, and charts, as well as an analysis of the data. The Visual…
Hair Transplant Market by Therapy (Platelet-Rich Plasma Therapy (PRP), Stem Cell …
Hair transplant refers to the market for surgical procedures aimed at restoring hair growth in individuals experiencing hair loss or baldness. These procedures involve the transplantation of hair follicles from one part of the body to the balding or thinning areas.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-hair-transplant-market
The expansion of biotechnology sector across the globe, acts as one of the major factors driving the growth of global hair transplant market. The increase in the…
Melanoma Therapeutics Market By Chemotherapy, Biologic therapy, Targeted therapy …
Melanoma market has witnessed an unprecedented boost in market size, owing to a dynamically evolving nature of melanoma treatments over the past few years. The high demand of novel early stage and advanced melanoma therapies along with a booming patient base, has created an impending need for better therapies in the melanoma market. Although, a plethora of treatment options are available today, several immunotherapies and combination therapies are expected to…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights:
• Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026
• Cell Therapy Clinical Trial Insight by Indication, Company & Country
• Global Cell Therapy Clinical Pipeline: 767 Cell Therapies
• Globally Marketed Cell Therapies: 25 Cell Therapies
• Maximum Number of Marketed Cell Therapies In USA: 15 Therapies
• Price & Product Insight By Region/Country
• Regional Analysis of the Cell Therapy Market
Download…
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,…
